CAL
CERE

Capital Advisors Ltd’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Capital Advisors Ltd’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11
Closed – – 1663
2024
Q2 		$0 Hold
11
– – ﹤0.01% 1703
2024
Q1 		$0 Hold
11
– – ﹤0.01% 1602
2023
Q4 		$0 Buy
+11
New +$316 ﹤0.01% 1532

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Capital Advisors Ltd's CERE Position: Q3 2024 in Review

Capital Advisors Ltd sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 11 shares.

Capital Advisors Ltd first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $0 in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Capital Advisors Ltd reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Capital Advisors Ltd sold 11 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024.
  • Capital Advisors Ltd first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Capital Advisors Ltd's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $0 in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Capital Advisors Ltd's 13F filing for Q3 2024, filed 24 Oct 2024.